02/26/2026
We always prefer whole mushrooms to synthetic formulas.
People have said for years that whole shrooms feel distinct from synthetic psilocybin.
Scientists shrugged it off, but a new study in Scientific Reports just mapped out the mechanics, and the case for a mushroom "entourage effect" is now seriously compelling.
Murray's team screened 15 compounds found in Psilocybe mushrooms and found eight that survive digestion and cross the blood-brain barrier.
Eight brain-active molecules in a single bite.
They hit 44 protein targets across serotonin, dopamine, and neuroplasticity pathways as a coherent network.
it seems mushrooms may run the same trick as ayahuasca. Three β-carbolines in the mushroom bind to MAO-A, the enzyme that breaks down serotonin and psilocin.
So the mushroom delivers the psychedelic and the thing that slows its breakdown, all in one organism.
A built-in potentiation system, evolved over millions of years.
This isn't just theory.
Mouse studies already showed crude mushroom extract outperformed pure psilocybin for anxiety. Whole extracts alter synaptic proteins differently than synthetic psilocybin. And patients consistently report preferring mushroom-derived experiences.
The computational model now gives us a mechanistic why behind all of that.
Maybe in our rush to isolate the "active ingredient," we've been ignoring the system it evolved within.
The magic in the mushroom is not just psilocybin. Its the conversation between compounds.
And that conversation, this research suggests, may be where the deeper therapeutic potential resides.